LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
Year | Revenue |
---|---|
Mar2024 | ₹104 Cr |
Mar2023 | ₹130 Cr |
Mar2022 | ₹137 Cr |
Mar2021 | ₹202 Cr |
Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹104 Cr | -19.47 | |
Mar2023 | ₹130 Cr | -5.51 | |
Mar2022 | ₹137 Cr | -32.24 | |
Mar2021 | ₹202 Cr | 21.00 | |
Mar2020 | ₹167 Cr | - |
Compare Revenue of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹75.2 Cr | -12.1% | -13.9% | -36.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | 0.2% | -8.3% | 15.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -1.9% | 8.6% | 55.9% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -1.3% | -5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -0.5% | -4.2% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.7% | 5.8% | 6.1% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -12.1% |
-13.9% |
-36.8% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses